OncoTargets and Therapy
Country
New Zealand
Pacific Region
Subject Area and Category
Medicine
└
Oncology
Q2
└
Pharmacology (medical)
Q2
Publisher
SJR 2025
0.800
Q2
SJR Score
H-Index
100
Citations / Doc (2yr)
2.34
Total Docs. (latest)
97
Total Citations (3yr)
795
Publication type
Journals
ISSN
11786930
Coverage
2009-2026
Journal Rank
#6,914
Subject Categories
Oncology
Q2
Pharmacology (medical)
Q2
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 97 |
| Total Docs. (3 years) | 297 |
| Total Refs. | 4,934 |
| Total Citations (3 years) | 795 |
| Citable Docs. (3 years) | 292 |
| Citations / Doc. (2 years) | 2.34 |
| Ref. / Doc. | 50.87 |
| % Female | 45.3% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of OncoTargets and Therapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, OncoTargets and Therapy has an SJR of 0.800 and is ranked Q2.
What is the SJR and quartile of OncoTargets and Therapy?
OncoTargets and Therapy has an SJR (SCImago Journal Rank) of 0.800 and its best quartile is Q2.
What is the H-index of OncoTargets and Therapy?
The H-index of OncoTargets and Therapy is 100, meaning 100 of its articles have each been cited at least 100 times.
Is OncoTargets and Therapy indexed in Scopus?
Yes. OncoTargets and Therapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.